People
Mingxi Li
Mingxi Li is a partner at GT Healthcare Capital Partners focused on life-science technology and cross-border commercialization. The manager describes earlier Jiuding healthcare investing and Simcere work, including a senior-director position in2013–2017. He studied biological science and biotechnology at Tsinghua University and earned a biochemistry PhD at the University of Illinois Urbana-Champaign. Apeiron Therapeutics’ current primary team biography identifies the same scientist as its CEO and a GT partner, providing a genuine name-bound portrait. His former Simcere portfolio responsibility is career history, not a GT fund closing or personal cash investment. He is distinct from an unrelated New York internal-medicine physician with the same name.